Safety study of Safety and Efficacy of BIIB104 in schizophrenia
This study is completed in the United States, in the United Kingdom, in Germany, .... It is testing Safety and Efficacy of BIIB104 for schizophrenia.
In United Kingdom
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States, in the United Kingdom, in Germany, .... It is testing Safety and Efficacy of BIIB104 for schizophrenia.
In United KingdomThis study is completed in Canada, in the United Kingdom, in Switzerland, .... It focuses on ADHD.
In United KingdomThis study was terminated in the United States, in Australia, in France, .... It focuses on schizophrenia.
In United KingdomThis study is completed in France, in the United Kingdom, in Belgium, .... It focuses on Schizophrenia.
In United KingdomThis study is ongoing in the United Kingdom. It focuses on Depression.
In United KingdomThis study is completed. It focuses on ADHD and currently lists study information in the United Kingdom.
In United KingdomThis study is completed. It focuses on schizophrenia and currently lists study information in the United Kingdom.
In United KingdomThis study has public registry information. It focuses on depression and currently lists study information in the United Kingdom.
Remote / onlineThis study is completed. It focuses on ADHD and currently lists study information in Austria, Belgium, France, Germany, Ireland, Italy, the Netherlands, Poland, Romania, Spain, Sweden, Ukraine, and the United Kingdom.
In United KingdomThis study is completed. It focuses on anxiety and currently lists study information in the United Kingdom.
In United KingdomThis study is completed. It focuses on ADHD and currently lists study information in the United Kingdom.
In United KingdomThis study is active but not recruiting. It focuses on ADHD and currently lists study information in Spain and the United Kingdom.
Remote / onlineHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.